Psychedelic medicine gets a boost

By Politico
| February 15, 2024

The Food and Drug Administration has accepted Lykos Therapeutics' new drug application for psychedelic-assisted therapy, teeing up 2024 as a potentially transformative year for psychedelic medicine.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...